PharmiWeb

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. MIAMI, FLORIDA / ACCESS ...
PharmiWeb

Ensysce Biosciences Issues Annual Shareholder Letter

PF614-301 Phase 3 Trial Enrollment Underway, Advancing Toward Market LaunchFDA Aligned with ENSC Manufacturing Path for PF614, Enabling Commercial Scale UpMPAR® Patent Protection Extended Through ...
PharmiWeb

IGC Pharma Raises Capital to Advance IGC-AD1 Phase 2 Trial

New Financing Supports Disciplined Clinical Execution and Value Creation in Alzheimer's Drug Development - POTOMAC, MARYLAND / ACCESS Newswire / January 5, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ...
PharmiWeb

Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
PharmiWeb

BioInvent Reports Promising Data from Ongoing Phase 2a study for BI-1808 with KEYTRUDA(R) (pembrolizumab) in Recurrent Ovarian Cancer

ORR for BI-1808 combined with pembrolizumab represents a meaningful improvement over pembrolizumab monotherapy in recurrent ovarian cancer (8% ORR in KEYNOTE-100)The combination demonstrated a ...
PharmiWeb

Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs

Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief ...
PharmiWeb

Through High-Profile Ambassadors and Major Partnerships, ZetrOZ Systems Expanded Reach of sam Device in 2025

The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations to ...
PharmiWeb

Shareholders Russell Budd and Scott Summy Named to the 2026 Lawdragon Hall of Fame

Baron & Budd President and Managing Shareholder Russell Budd, along with Shareholder and leader of the Environmental ...
PharmiWeb

Dr. Mendez Explains How a Dual Approach Using Surgery and SRT Helps Manage Persistent Keloids

The Miami Beach keloid specialist outlines why pairing surgical excision with superficial radiation therapy can reduce recurrence and improve long-term comfort. MIAMI BEACH, FLORIDA / ACCESS Newswire ...
PharmiWeb

Middle East Health IT Modernization Is Accelerating But Procurement Is Tightening Around Bilingual Operations, Sovereign Hosting, and Verifiable AI

Black Book Survey of health IT leaders across five high-activity Middle East markets finds sovereignty-compatible architectures and Arabic/English workflow readiness are now pass/fail gates-while AI ...
PharmiWeb

Desert Oasis Healthcare Raises Awareness About Mpox with Community Podcast Featuring Local Advocates and Leaders

Desert Oasis Healthcare leads community-wide effort to raise awareness and encourage vaccination amid ongoing mpox concerns. PALM SPRINGS, CALIFORNIA / ACCESS Newswire / December 30, 2025 / Desert ...
PharmiWeb

Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and ...

The "Biological Therapies for Cancer: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global biological therapies market for cancer is expected to grow ...